Solid Tumours
Ideate-Pantumor02
A phase 2 pan tumour, open label study to evaluate the efficacy and safety of Ifinatamab Deruxtecan (I-DXD) in subjects with recurrent or metastatic solid tumours.
Trial overview
Clinical Area
Medical Oncology
Disease
Basket - Metastic
Disease site
Basket
Study Phase
II
Trial Identifiers
Registration number: NCT06330064
GenesisCare Location(s)
Principal Investigator(s)
Clinical trials enquiries